Malaria: New developments in treatment and prevention

Annual Review of Medicine

Volumn 50, Issue , 1999, Pages 179-192

  Newton, Paul ^a   White, Nicholas ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Falciparum; Plasmodium; Prophylaxis; Therapy

Indexed keywords

8 [4 (3 ACETYL 4,5 DIHYDRO 2 FURYLAMINO) 1 METHYLBUTYLAMINO] 6 METHOXYQUINOLINE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ARTESUNATE; ATOVAQUONE; BENFLUMETOL; CHLOROQUINE; CLINDAMYCIN; FANSIDAR; HALOFANTRINE; MALARIA VACCINE; MALOPRIM; MEFLOQUINE; METAKELFIN; PRIMAQUINE; PROGUANIL; PYRIMETHAMINE; PYRONARIDINE; QUINIDINE; QUINIMAX; QUININE; SULFADOXINE; TETRACYCLINE;

ANOREXIA; BED NET; DISEASE TRANSMISSION; DRUG TOLERABILITY; HUMAN; INCIDENCE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALARIA; MENTAL DISEASE; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TROPICS; VERTIGO; VOMITING;

ANTIMALARIALS; ARTEMISININS; BEDDING AND LINENS; DRUG COSTS; DRUG RESISTANCE; DRUGS, CHINESE HERBAL; HUMANS; INCIDENCE; MALARIA; MALARIA VACCINES; MALARIA, FALCIPARUM; PROTECTIVE DEVICES; SESQUITERPENES; TROPICAL CLIMATE;

EID: 0032977446     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.50.1.179     Document Type: Review

References (56)

1. 1. Ross R. 1931. In In Exile, p. 73. London: John Murray. 77 pp.
2. 1a.White NJ. 1996. Malaria. In Manson's Tropical Diseases, ed. G Cook, pp. 1087-164. London: Saunders
3. 2. Payne D. 1988. Did medicated salt hasten the spread of chloroquine resistance in Plasmodium falciparum? Parasitol. Today 4:112-15
4. 3. Su X, Kirkman LA, Fujioka H, Wellems TE. 1997. Complex polymorphisms in an ∼330 kDa protein are linked to chloroquine-resistant P. falciparum in Southeast Asia and Africa. Cell 91: 593-603
5. 4. WHO. 1997. Management of uncomplicated malaria and the use of antimalarial drugs for the protection of travellers. WHO/MAL/96.1075 Rev 1. World Health Organ., Geneva
6. 5. Liu DQ, Liu RJ, Ren DX, et al. 1995. Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China. Bull. World Health Organ. 73: 483-86
7. 6. Pukrittayakamee S, Supanaranond W, Looareesuwan S, et al. 1994. Quinine in severe falciparum malaria: evidence of declining efficacy in Thailand. Trans. R. Soc. Trop. Med. Hyg. 88:324-27
8. 7. Nosten F, van Vugt M. 1996. Malaria: still no vaccine and very few drugs. Curr. Opin. Infect. Dis. 9:429-34
9. 8. White NJ. 1992. Antimalarial drug resistance: the pace quickens. J. Antimicrob. Chemother. 30:571-85
10. 9. Whitby M. 1997. Drug resistant Plasmodium vivax malaria. J. Antimicrob. Chemother. 40: 749-52
11. 10. White NJ. 1997. Assessment of the pharmacodynamic properties of antimalarial drugs in vivo. Antimicrob. Agents Chemother. 41:1413-22
12. 11. Price RN, Nosten F, Luxemburger C, et al. 1996. Effects of artemisinin derivatives on malaria transmissibility. Lancet 347:1654-58
13. 12. Baird JK, Hoffman SL. 1996. Progress in prevention and treatment of malaria. Curr. Opin. Infect. Dis. 9:319-29
14. 13. Slater F, Cerami A. 1992. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 355:167-69
15. 14. Kremsner PG, Radloff P, Metzger W, et al. 1994. Quinine plus clindamycin improves chemotherapy of severe malaria in children. Antimicrob. Agents Chemother. 39:1603-5
16. 15. Sowunmi A, Oduola AMJ, Ogundahunsi OAT, Salako LA. 1998. Comparative efficacy of chloroquine plus chlorpheniramine and pyrimethamine/sulfadoxine in acute uncomplicated falciparum malaria in Nigerian children. Trans. R. Soc. Trop. Med. Hyg. 92:77-81
17. 16. WHO. 1990. Severe and complicated malaria. Trans. R. Soc. Trop. Med. Hyg. 84: 1-65 (Suppl.)
18. 17. Watt G, Loesuttivibool L, Shanks GD, et al. 1992. Quinine with tetracycline for the treatment of drug-resistant falciparum malaria in Thailand. Am. J. Trop. Med. Hyg. 47:108-11
19. 18. Mai NT, Day NP, Hien TT, White NJ. 1996. Neurological sequelae of cerebral malaria. Lancet 348:1658-59
20. 19. Nosten F, Price RN. 1995. New antimalarials. A risk-benefit analysis. Drug Saf. 12:264-73
21. 20. White NJ. 1996. The treatment of malaria. N. Engl. J. Med. 335:800-6
22. 21. Meshnik SR, Taylor TE, Kamchonwongpaisan S. 1996. Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy. Microbiol. Rev. 60:301-15
23. 22. Hien TT, White NJ. 1993. Qinghaosu. Lancet 341:603-8
24. 23. Petras JM, Kyle DE, Gettayacamin M, et al. 1997. Arteether: risks of two-week administration in Macaca mulatta. Am. J. Trop. Med. Hyg. 56:390-6
25. 24. Kiatfuengfoo R, Suthiphongchai T, Prapunwttana P, Yuthavong Y. 1989. Mitochondria as the site of action of tetracycline on Plasmodium falciparum. Mol. Biochem. Parasitol. 34:109-116
26. 25. Watt G, Shanks GD, Edstein MD, et al. 1991. Ciprofloxacin treatment of drug-resistant falciparum malaria. J. Infect. Dis. 164:602-4
27. 26. White NJ, Looareesuwan S, Phillips RE, et al. 1988. Single dose phenobarbitone prevents convulsions in cerebral malaria. Lancet 2:64-66
28. 27. Warrell DA, Looareesuwan S, Warrell MJ, et al. 1982. Dexamethasone proves deleterious in cerebral malaria: a double-blind trial in 100 comatose patients. N. Engl. J. Med. 306:313-19
29. 28. Hemmer CJ, Kern P, Holst FGE, et al. 1991. Neither heparin nor acetylsalicylic acid influence the clinical course in human Plasmodium falciparum malaria: a prospective randomized study. Am. J. Trop. Med. Hyg. 45:608-12
30. 29. Hoontrakoon S, Suputtamongkol Y. 1998. Exchange transfusion as an adjunct to the treatment of severe falciparum malaria. Trop. Med. Int. Health 3:156-61
31. 30. Clark IA, Rockett KA. 1994. The cytokine theory of human cerebral malaria. Parasitol. Today 10:410-12
32. 31. Kwiatkowski D, Molyneux ME, Stephens S, et al. 1993. Anti-TNF therapy inhibits fever in cerebral malaria. Q. J. Med. 86: 91-98
33. 32. Perri GD, Perri IGD, Monteiro GB, et al. 1995. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J. Infect. Dis. 171:1317-22
34. 33. Looareesuwan S, Wilairatana P, Vannaphan S, et al. 1998. Pentoxifylline as an ancillary treatment for severe falciparum malaria in Thailand. Am. J. Trop. Med. Hyg. 58:348-53
35. 34. Gordeuk V, Thuma P, Brittenham G, et al. 1992. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N. Engl. J. Med. 327: 1473-77
36. 35. Krishna S, Supanaranond W, Pukrittayakamee S, et al. 1994. Dichloroacetate for lactic acidosis in severe malaria: a pharmacokinetic and pharmacodynamic assessment. Metabolism 43:974-81
37. 36. Murphy GS, Oldfield EC. 1996. Falciparum malaria. Infect. Dis. Clin. No. Am. 10:747-75
38. 37. Nosten F, ter Kule F, Maelankri L, et al. 1994. Mefloquine prophylaxis prevents malaria during pregnancy: a double-blind, placebo-controlled study. J. Infect. Dis. 169:595-603
39. 38. White NJ, Ho M. 1992. The pathophysiology of malaria. In Advances in Parasitology, ed. RM Baker, pp. 84-175. London: Academic
40. 39. Looareesuwan S, Wilairatana P, Vanijanonta S, et al. 1996. Treatment of acute, uncomplicated, falciparum malaria with oral dihydroartemisinin. Ann. Trop. Med. Parasitol. 90:21-28
41. 40. Lell B, Luckner D, Ndjave M, et al. 1998. Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children. Lancet 351:709-13
42. 41. Van Vugt M, Brockman A, Gemperli B, et al. 1998. Randomised comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug resistant falciparum malaria. Antimicrob. Agents Chemother. 42:135-39
43. 42. Looareesuwan S, Kyle DE, Viravan C, et al. 1996. Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. Am. J. Trop. Med. Hyg. 54:205-9
44. 43. White NJ, Nosten F. 1993. Advances in chemotherapy and prophylaxis of malaria. Curr. Opin. Infect. Dis. 6:323-30
45. 44. White NJ, Olliaro PL. 1996. Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. Parasitol. Today 12: 399-401
46. 45. Crandall I, Collins WE, Gysin J, Sherman IW. 1993. Synthetic peptides based on motifs present in human band 3 protein inhibit cytoadherence/sequestration of the malaria parasite Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 90: 4703-7
47. 46. Scherf A, Pouvelle B, Hernandex-Rivas R, et al. 1997. Sequestration of P. falciparum infected erythrocytes to chondroitin sulphate A: desequestration by soluble CSA in vivo and cloning of the parasite counter-receptor. Proc. 2nd Global Meet. Parasitic Dis., Hyderabad, p. 83
48. 47. Greenwood AM, Menendez C, Alonso PL, et al. 1994. Can malaria chemoprophylaxis be restricted to first pregnancies? Trans. R. Soc. Trop. Med Hyg. 88: 681-82
49. 48. Bradley DJ, Warhurst DC. 1995. Malaria prophylaxis: guidelines for travellers from Britain. Br. Med. J. 310:709-13
50. 49. Ohrt C, Richie TL, Widjaja H, et al. 1997. Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. Ann. Intern. Med. 126: 963-72
51. 50. Fryauff DJ, Baird JK, Basri H, et al. 1995. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Lancet 346:1190-93
52. 51. Choi HW, Breman JG, Teutsch SM, et al. 1995. The effectiveness of insecticide-impregnated bed nets in reducing cases of malaria infection: a meta-analysis of published results. Am. J. Trop. Med. Hyg. 52:377-82
53. 52. Snow RW, Omumbo JA, Lowe B, et al. 1997. Relation between severe malaria morbidity in children and level of Plasmodium faciparum transmission in Africa. Lancet 349:1650-54
54. 53. Menendez C, Kahigwa E, Hirt R, et al. 1997. Randomised placebo-controlled trial of iron supplementation and malaria prophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 350:844-50
55. 54. Kwiatowski D, Marsh K. 1997. Development of a malaria vaccine. Lancet 350: 1696-1701
56. 55. Stoute JA, Slaoui M, Heppner G, et al. 1997. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N. Engl. J. Med. 336:86-91